Skip to search formSkip to main contentSkip to account menu

MK 0517

Known as: MK-0517, MK0517 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

aprepitant

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Fosaprepitant dimeglumine (MK-0517 or L-785,298), an intravenous neurokinin-1 antagonist for the prevention of chemotherapy induced nausea and vomiting
Background: This paper reviews the existing literature on fosaprepitant, an intravenous neurokinin-1 anatgonist for the… 
Review
2008
Review
2008
Fosaprepitant dimeglumine (MK-0517 or L-785,298), an intravenous neurokinin-1 antagonist for the prevention of chemotherapy induced nausea and vomiting.
BACKGROUND This paper reviews the existing literature on fosaprepitant, an intravenous neurokinin-1 anatgonist for the prevention… 
Review
2008
Review
2008
Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting
  • R. Navari
  • Expert Review of Anticancer Therapy
  • 2008
  • Corpus ID: 24595976
Chemotherapy-induced nausea and vomiting (CINV) is a distressing and common adverse event associated with cancer treatment… 
Review
2007
Review
2007
Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting
  • R. Navari
  • Expert Opinion on Investigational Drugs
  • 2007
  • Corpus ID: 21437603
Chemotherapy-induced nausea and vomiting (CINV) is a distressing and common adverse event associated with cancer treatment… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)